BIOMAT Database Logo BIOMAT Database Logo

[Role of glucagon in the treatment of acute pancreatitis]. 1978

S Ancyparowicz, and A Kawalski, and M Klukowski, and W Piotrowicz

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010195 Pancreatitis INFLAMMATION of the PANCREAS. Pancreatitis is classified as acute unless there are computed tomographic or endoscopic retrograde cholangiopancreatographic findings of CHRONIC PANCREATITIS (International Symposium on Acute Pancreatitis, Atlanta, 1992). The two most common forms of acute pancreatitis are ALCOHOLIC PANCREATITIS and gallstone pancreatitis. Acute Edematous Pancreatitis,Acute Pancreatitis,Pancreatic Parenchyma with Edema,Pancreatic Parenchymal Edema,Pancreatitis, Acute,Pancreatitis, Acute Edematous,Peripancreatic Fat Necrosis,Acute Edematous Pancreatitides,Acute Pancreatitides,Edema, Pancreatic Parenchymal,Edematous Pancreatitides, Acute,Edematous Pancreatitis, Acute,Fat Necrosis, Peripancreatic,Necrosis, Peripancreatic Fat,Pancreatic Parenchymal Edemas,Pancreatitides, Acute,Pancreatitides, Acute Edematous,Parenchymal Edema, Pancreatic,Peripancreatic Fat Necroses
D005260 Female Females
D005934 Glucagon A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511) Glucagon (1-29),Glukagon,HG-Factor,Hyperglycemic-Glycogenolytic Factor,Proglucagon (33-61),HG Factor,Hyperglycemic Glycogenolytic Factor
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

S Ancyparowicz, and A Kawalski, and M Klukowski, and W Piotrowicz
[Glucagon treatment in acute pancreatitis].
January 1979, Duodecim; laaketieteellinen aikakauskirja,
S Ancyparowicz, and A Kawalski, and M Klukowski, and W Piotrowicz
[Glucagon treatment of acute pancreatitis].
June 1979, Revista espanola de las enfermedades del aparato digestivo,
S Ancyparowicz, and A Kawalski, and M Klukowski, and W Piotrowicz
[Treatment of acute pancreatitis using glucagon].
June 1974, Zentralblatt fur Chirurgie,
S Ancyparowicz, and A Kawalski, and M Klukowski, and W Piotrowicz
Glucagon treatment of experimental acute pancreatitis.
January 1975, Acta medica Academiae Scientiarum Hungaricae,
S Ancyparowicz, and A Kawalski, and M Klukowski, and W Piotrowicz
[Treatment of acute pancreatitis with glucagon].
May 1979, Minerva chirurgica,
S Ancyparowicz, and A Kawalski, and M Klukowski, and W Piotrowicz
Letter: Glucagon in treatment of acute pancreatitis.
June 1974, Lancet (London, England),
S Ancyparowicz, and A Kawalski, and M Klukowski, and W Piotrowicz
[Use of glucagon in the treatment of acute pancreatitis].
May 1975, Minerva chirurgica,
S Ancyparowicz, and A Kawalski, and M Klukowski, and W Piotrowicz
[Glucagon in the treatment of acute pancreatitis (clinical contribution)].
April 1976, Chirurgia italiana,
S Ancyparowicz, and A Kawalski, and M Klukowski, and W Piotrowicz
Possible role of glucagon in pathogenesis of acute pancreatitis.
May 1972, Lancet (London, England),
S Ancyparowicz, and A Kawalski, and M Klukowski, and W Piotrowicz
The role of pancreatic glucagon in the pathogenesis of acute pancreatitis.
November 1972, Clinical science,
Copied contents to your clipboard!